Skip to main content

Advertisement

SpringerLink
Log in

High FUT3 expression is a marker of lower overall survival of breast cancer patients

  • Original Article
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

The complex enzyme network responsible for glycan synthesis suffers significant changes during the first steps of tumor development, leading to the early formation of tumor-associated glycan signatures. Among the glycosylation pathways, changes in fucosylation emerged as one of most important features in cancer. Αlpha-1,3/4-fucosyltransferase (FUT3) has been linked to pro-tumor and anti-tumor pathways depending on the cancer type. The present study aimed to understand the gene and protein expression profiles of FUT3 in three different and independent cohorts composed by invasive breast cancer patients: Local Brazilian population, METABRIC and TCGA. FUT3 transcripts and protein were measured in the Brazilian population by real-time PCR and Western blotting, respectively. Clinical records and FUT3 levels from public METABRIC and TCGA cohorts were accessed through CBioPortal database. FUT3 expression was analyzed in each cohort using the appropriated statistic tools. Survival meta-analysis in triple negative patients was performed using five independent cohorts including GSE41119, GSE47994 and GSE86945, data obtained from GEO repository available at NCBI database, and METABRIC and TCGA. Our analysis showed that high FUT3 levels were consistently associated to reduced invasive breast cancer patients overall survival. This finding is particularly significant in triple negative patients. These results together with the previously knowledge regarding the involvement of FUT3 in pro-tumor and anti-tumor mechanisms led us to purpose a model for FUT3 expression regulation throughout breast cancer establishment and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A.: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018)

    Article  PubMed  Google Scholar 

  2. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 136(5), E359–E386 (2015)

    Article  CAS  PubMed  Google Scholar 

  3. Colomer, R., Aranda-López, I., Albanell, J., García-Caballero, T., Ciruelos, E., López-García, M.Á., Cortés, J., Rojo, F., Martín, M., Palacios-Calvo, J.: Biomarkers in breast cancer: a consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clin. Transl. Oncol. 20(7), 815–826 (2018)

    Article  CAS  PubMed  Google Scholar 

  4. Yadav, B.S., Chanana, P., Jhamb, S.: Biomarkers in triple negative breast cancer: a review. World J. Clin. Oncol. 6(6), 252–263 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dube, D.H., Bertozzi, C.R.: Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4(6), 477–488 (2005)

    Article  CAS  PubMed  Google Scholar 

  6. Pinho, S.S., Reis, A.R.: Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer. 15(9), 540–555 (2015)

    Article  CAS  PubMed  Google Scholar 

  7. Colomb, F., Robbe-Masselot, C., Groux-Degroote, S., Bouckaert, J., Delannoy, P., Michalski, J.: Epithelial mucins and bacterial adhesion. J. Carbohyd. Chem. 40, 596–623 (2014)

    Article  CAS  Google Scholar 

  8. Jeschke, U., Mylonas, I., Shabani, N., Kunert-Keil, C., Schindlbeck, C., Gerber, B., Friese, K.: Expression of Sialyl Lewis X. Sialyl Lewis A, E-Cadherin and Cathepsin-D in Human Breast Cancer: Immunohistochemical Analysis in Mammary Carcinoma In Situ. Anticancer Res. 25(3A), 1615–1622 (2005)

    CAS  PubMed  Google Scholar 

  9. Czerwinski, M.J., Desiderio, V., Shkeir, O., Papagerakis, P., Lapadatescu, M.C., Owen, J.H., Athanassiou-Papaefthymiou, M., Zheng, L., Papaccio, G., Prince, M.E., Papagerakis, S.: In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells. Otolaryngol. Head Neck Surg. 149(1), 97–104 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  10. Borzym-Kluczyk, M., Radziejewska, I., Cechowska-Pasko, M.: Increased expression of MUC1 and sialyl Lewis antigensin different areas of clear renal cell carcinoma. Clin. Exp. Nephrol. 19(4), 732–737 (2015)

    Article  CAS  PubMed  Google Scholar 

  11. Burdick, M.M., Henson, K.A., Delgadillo, L.F., Choi, Y.E., Goetz, D.J., Tees, D.F., Benencia, F.: Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways? Front. Oncol. 2, 103 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hirakawa, M., Takimoto, R., Tamura, F., Yoshida, M., Ono, M., Murase, K., Sato, Y., Osuga, T., Sato, T., Iyama, S., Miyanishi, K., Takada, K., Hayashi, T., Kobune, M., Kato, J.: Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br. J. Cancer. 110(1), 156–163 (2014)

    Article  CAS  PubMed  Google Scholar 

  13. Higai, K., Ichikawa, A., Matsumoto, K.: Binding of sialyl Lewis X antigen to lectin-like receptors on NK cells induces cytotoxicity and tyrosine phosphorylation of a 17-kDa protein. Biochim. Biophys. Acta. 1760(9), 1355–1363 (2006)

    Article  CAS  PubMed  Google Scholar 

  14. Zhang, B., Van Roosmalen, I.A.M., Reis, C.R., Setroikromo, R., Quax, W.J.: Death receptor 5 is activated by fucosylation in colon cancer cells. FEBS J. 286(3), 555–571 (2019)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Vasconcelos, J.L.A., Ferreira, S.A., Lima, A.L., Rêgo, M.J.M., Bandeira, A.R., Cavalcanti, C.L.B., Lira, M.M.M., Beltrão, E.I.: Comparing the Immunoexpression of FUT3 and FUT6 between prostatic adenocarcinoma and benign prostatic hyperplasia. Acta Histochem. Cytochem. 46(3), 105–109 (2013)

    Article  CAS  Google Scholar 

  16. Vajaria, B.N., Patel, K.R., Begum, R., Shah, F.D., Patel, J.B., Joshi, G.M., Patel, P.S.: Expression of Glycosyltransferases; ST3GAL1, FUT3, FUT5, and FUT6b transcripts in Oral Cancer. Glycobiol. Insights. 4, 7–14 (2014)

    Article  Google Scholar 

  17. Nascimento, J.C.F., Ferreira, S.A., Vasconcelos, J.L.A., Silva-Filho, J.L., Barbosa, B.T., Bezerra, M.F., Rocha, C.R., Beltrão, E.I.: Fut3 role in breast invasive ductal carcinoma: investigating its gene promoter and protein expression. Exp. Mol. Pathol. 99(3), 409–415 (2015)

    Article  CAS  PubMed  Google Scholar 

  18. Meng, L., Xu, L., Yang, Y., Zhou, L., Chang, Y., Shi, T., Tan, C., An, H., Zhu, Y., Xu, J.: High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma. Oncotarget. 8(37), 61036–61047 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  19. Aubert, M., Panicot-Dubois, L., Crotte, C., Sbarra, V., Lombardo, D., Sadoulet, M.O., Mas, E.: Peritoneal colonization by human pancreatic cancer cells is inhibited by antisense FUT3 sequence. Int. J. Cancer. 88(4), 558–565 (2000)

    Article  CAS  PubMed  Google Scholar 

  20. Barthel, S.R., Wiese, G.K., Cho, J., Opperman, M.J., Hays, D.L., Siddiqui, J., Pienta, K.J., Furie, B., Dimitroff, C.J.: Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc. Natl. Acad. Sci. U. S. A. 106(46), 19491–19496 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Carrascal, M.A., Silva, M., Ramalho, J.S., Pen, C., Martins, M., Pascoal, C., Amaral, C., Serrano, I., Oliveira, M.J., Sackstein, R., Videira, P.A.: Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation. Mol. Oncol. 12(5), 579–593 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ma, H., Miao, X., Ma, Q., Zheng, W., Zhou, H., Jia, L.: Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells. IUBMB Life. 65(5), 409–422 (2013)

    Article  CAS  PubMed  Google Scholar 

  23. Breiman, A., Robles, M.D.L., Trécesson, S.C., Echasserieau, K., Bernardeau, K., Drickamer, K., Imberty, A., Barillé-Nion, S., Altare, F., Le Pendu, J.: Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin). Oncotarget. 7(12), 14064–14082 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  24. Julien, S., Ivetic, A., Grigoriadis, A., QiZe, D., Burford, B., Sproviero, D., Picco, G., Gillett, C., Papp, S.L., Schaffer, L., Tutt, A., Taylor-Papadimitriou, J., Pinder, S.E., Burchell, J.M.: Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res. 71(24), 7683–7693 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Liu, L.L., Zhao, H., Ma, T.F., Ge, F., Chen, C.S., Zhang, Y.P.: Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast Cancer cell lines treated with and without transient transfection. PLoS One. 10(1), e0117058 (2015)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Nascimento, J.C.F., Vasconcelos, A.O., Seabra, M.A.B.L., Beltrão, E.I.C., Rocha, C.R.C.: The challenge of determining the impact of FUT3 tumor-associated polymorphism rs2306969 (−6951 C> T) in invasive breast cancer cells. Mol. Biol. Rep. 46(3), 3531–3536 (2019)

    Article  PubMed  CAS  Google Scholar 

  27. Pereira, B., Chin, S.F., Rueda, O.M., Vollan, H.K., Provenzano, E., Bardwell, H.A., Pugh, M., Jones, L., Russell, R., Sammut, S.J., Tsui, D.W., Liu, B., Dawson, S.J., Abraham, J., Northen, H., Peden, J.F., Mukherjee, A., Turashvili, G., Green, A.R., McKinney, S., Oloumi, A., Shah, S., Rosenfeld, N., Murphy, L., Bentley, D.R., Ellis, I.O., Purushotham, A., Pinder, S.E., Børresen-Dale, A.L., Earl, H.M., Pharoah, P.D., Ross, M.T., Aparicio, S., Caldas, C.: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat. Commun. 7, 11479 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ciriello, G., Gatza, M.L., Beck, A.H., Wilkerson, M.D., Rhie, S.K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., Bowlby, R., Shen, H., Hayat, S., Fieldhouse, R., Lester, S.C., Tse, G.M., Factor, R.E., Collins, L.C., Allison, K.H., Chen, Y.Y., Jensen, K., Johnson, N.B., Oesterreich, S., Mills, G.B., Cherniack, A.D., Robertson, G., Benz, C., Sander, C., Laird, P.W., Hoadley, K.A., King, T.A.: Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 163(2), 506–519 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Prat, A., Adamo, B., Cheang, M.C.U., Anders, C.K., Carey, L.A., Perou, C.M.: Molecular characterization of basal-like and non-basal-like triple-negative breast Cancer. Oncologist. 18, 123–133 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Romero-Cordoba, S.L., Rodriguez-Cuevas, S., Bautista-Pina, V., Maffuz-Aziz, A., D'Ippolito, E., Cosentino, G., Baroni, S., Iorio, M.V., Hidalgo-Miranda, A.: Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer. Sci. Rep. 8, 12252 (2018)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Camp, R.L., Dolled-Filhart, M., Rimm, D.L.: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Can. Res. 10, 7252–7259 (2004)

    Article  CAS  Google Scholar 

  32. Guo, Y., Sheng, Q., Li, J., Ye, F., Samuels, D.C., Shyr, Y.: Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data. PLoS One. 8(8), e71462 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Duffy, M.J., Sturgeon, C.M., Sölétormos, G., Barak, V., Molina, R., Hayes, D.F., Diamandis, E.P., Bossuyt, P.M.: Validation of new cancer biomarkers: a position statement from the European group on tumor markers. Clin. Chem. 61(6), 809–820 (2015)

    Article  CAS  PubMed  Google Scholar 

  34. Xu, Z., Marko, N.F., Angelov, L., Barnett, G.H., Chao, S.T., Vogelbaum, M.A., Suh, J.H., Weil, R.J.: Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer. Cancer. 118(5), 1323–1333 (2012)

    Article  PubMed  Google Scholar 

  35. Fujii, T., Yajima, R., Hirakata, T., Miyamoto, T., Fujisawa, T., Tsutsumi, S., Ynagita, Y., Iijima, M., Kuwano, H.: Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer. Anticancer Res. 34(3), 1255–1259 (2014)

    PubMed  Google Scholar 

  36. Tang, C., Wang, P., Li, X., Zhao, B., Yang, H., Yu, H., Li, C.: Lymph node status have a prognostic impact in breast cancer patients with distant metastasis. PLoS One. 12(8), e0182953 (2017)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Li, Y., Steppi, A., Zhou, Y., Mao, F., Miller, P.C., He, M.M., Zhao, T., Sun, Q., Zhang, J.: Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine. Sci. Rep. 7(1), 4747 (2017)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Salzano, F.M., Sans, M.: Interethnic admixture and the evolution of Latin American populations. Genet. Mol. Biol. 37(1), 151–170 (2014)

    Article  PubMed  Google Scholar 

  39. Favé, M., Lamaze, F.C., Soave, D., Hodgkinson, A., Gauvin, H., Bruat, V., Grenier, J., Gbeha, E., Skead, K., Smargiassi, A., Johnson, M., Idaghdour, Y., Awadalla, P.: Gene-by-environment interactions in urban populations modulate risk phenotypes. Nat. Commun. 9(1), 827 (2018)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Duarte, H.O., Balmaña, M., Mereiter, S., Osório, H., Gomes, J., Reis, C.A.: Gastric Cancer cell glycosylation as a modulator of the ErbB2 oncogenic receptor. Int. J. Mol. Sci. 18(11), E2262 (2017)

    Article  PubMed  CAS  Google Scholar 

  41. Castellano, L., Giamas, G., Jacob, J., Coombes, R.C., Lucchesi, W., Thiruchelvam, P., Barton, G., Jiao, L.R., Wait, R., Waxman, J., Hannon, G.J., Stebbing, J.: The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U. S. A. 106(37), 15732–15737 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Zheng, Y., Shao, X., Huang, Y., Shi, L., Chen, B., Wang, X., Yang, H., Chen, Z., Zhang, X.: Role of estrogen receptor in breast cancer cell gene expression. Mol. Med. Rep. 13(5), 4046–4050 (2016)

    Article  CAS  PubMed  Google Scholar 

  43. Rahmatpanah, F.B., Jia, Z., Chen, X., Char, J.E., Men, B., Franke, A.C., Jones, F.E., McClelland, M., Mercola, D.: A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors. Oncotarget. 6(2), 1286–1301 (2015)

    Article  PubMed  Google Scholar 

  44. Gnant, M., Harbeck, N., Thomssen, C.: St. Gallen 2011: Summary of the Consensus Discussion. Breast Care. 6, 136–141 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  45. Balic, M., Thomssen, C., Würstlein, R., Gnant, M., Harbeck, N.: St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment. Breast Care. 14, 103–110 (2019)

    Article  PubMed  PubMed Central  Google Scholar 

  46. Park, Y.H., Lee, S.J., Cho, E.Y., Choi, Y.L., Lee, J.E., Nam, S.J., Yang, J.H., Shin, J.H., Ko, E.Y., Han, B.K., Ahn, S.J., Im, Y.H.: Clinical relevance of TNM staging system according tobreast cancer subtypes. Ann. Oncol. 22, 1554–1560 (2011)

    Article  CAS  PubMed  Google Scholar 

  47. Gonçalves Junior, H., Guerra, M.R., Cintra, J.R.D., Fayer, V.A., Brum, I.V., Teixeira, A.T.B.: Survival study of triple-negative and non–triple-negative breast Cancer in a Brazilian cohort. Clin. Med. Insights Oncol. 12, 1179554918790563 (2018)

    Google Scholar 

  48. Milde-Langosch, K., Karn, T., Schmidt, M., Zu Eulenburg, C., Oliveira-Ferrer, L., Wirtz, R.M., Schumacher, U., Witzel, I., Schütze, D., Müller, V.: Prognostic relevance of glycosylation-associated genes in breast cancer. Breast Cancer Res. Treat. 145(2), 295–305 (2014)

    Article  CAS  PubMed  Google Scholar 

  49. Cheng, T., Tu, S., Chen, L., Chen, M.Y., Chen, W.Y., Lin, Y.K., Ho, C.T., Lin, S.Y., Wu, C.H., Ho, Y.S.: Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface. Oncotarget. 6(25), 21283–21300 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  50. Bonin, S., Parascandolo, A., Aversa, C., Barbazza, R., Tsuchida, N., Castellone, M.D., Stanta, G., Vecchio, G.: Reduced expression of α-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients. Oncotarget. 9(20), 15228–15238 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  51. Esposito, M., Mondal, N., Greco, T.M., Wei, Y., Spadazzi, C., Lin, S.C., Zheng, H., Cheung, C., Magnani, J.L., Lin, S.H., Cristea, I.M., Sackstein, R., Kang, Y.: Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nat. Cell Biol. 21, 627–639 (2019)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Scully, O.J., Bay, B.H., Yip, G., Yu, Y.: Breast Cancer Metastasis. Cancer Genomics Proteomics. 9(5), 311–320 (2012)

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge Dr. George Siqueira and all the clinical and technical team from Hospital das Clínicas da Universidade Federal de Pernambuco (HC-UFPE, Brazil) for the support during the volunteers’ screening and sample collection. We also thank Professor Dayane Gomes from Universidade Federal de Pernambuco (Brazil) for the support during the execution of the Western blotting platform assays and Dr. Sandra L. Romero Cordoba from Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran (Mexico) to provide us the clinical data from GSE86945 cohort.

Funding

This study was funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) [grant number 480291/2011–0]; and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

Author information

Authors and Affiliations

  1. Universidade Federal de Pernambuco, Laboratório de Imunopatologia Keizo Asami, Recife, Pernambuco, Brazil

    Jessica Catarine Frutuoso do Nascimento, Eduardo Isidoro Carneiro Beltrão & Cíntia Renata Costa Rocha

  2. Department of Biochemistry, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil

    Eduardo Isidoro Carneiro Beltrão & Cíntia Renata Costa Rocha

Authors
  1. Jessica Catarine Frutuoso do Nascimento
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eduardo Isidoro Carneiro Beltrão
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cíntia Renata Costa Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Jessica Catarine Frutuoso do Nascimento. The first draft of the manuscript was written by Jessica Catarine Frutuoso do Nascimento and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Cíntia Renata Costa Rocha.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee (Comité de Ética em Pesquisa Envolvendo Seres Humanos do Centro de Ciências da Saúde da Universidade Federal de Pernambuco, CAAE 06586612.9.0000.5208 — Num. 140.876) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

do Nascimento, J.C.F., Beltrão, E.I.C. & Rocha, C.R.C. High FUT3 expression is a marker of lower overall survival of breast cancer patients. Glycoconj J 37, 263–275 (2020). https://doi.org/10.1007/s10719-020-09914-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-020-09914-2

Keywords

Search

Navigation